CompoAtlas

Arth Forte

Natural health product licensed in Canada

Licence holder
Rapha Canadian Natural
NPN or DIN-HM
80063967
Status
Active licence
Licence date
14 September 2015
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Méthylsulfonylméthane

Source : Sulfone de diméthyl

300 milligrammeNot calculated
Sulfate de chondroïtine

Source : Chondroïtin sulfate de sodium

175 milligrammeNot calculated
Sulfate de chondroïtine

Source : Bos taurus - cartilage

175 milligrammeNot calculated
Harpagophytum procumbens

Source : Racine(s) secondaire(s) tubérisée(s)

200 milligrammeNot calculated
Salix alba

Source : Jeune écorce de branche

Potency : 15 Pour cent Salicin

50 milligrammeNot calculated
Bromélaïne de tige

Source : Ananas comosus var. comosus - Tige

25 milligrammeNot calculated
Vitamine C

Source : Acide ascorbique

30 milligramme90,000 µg

Non-medicinal ingredients

Gélatine, Stéarate de magnésium, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule3 Tous les jours

Uses authorised in Canada

Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80063967

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line